Literature DB >> 13704260

The occurrence in nature of the Coxsackie and ECHO viruses.

H M GELFAND.   

Abstract

Keywords:  COXSACKIE VIRUSES; VIRUS DISEASES/transmission

Mesh：

Year:  1961        PMID： 13704260

Source DB:  PubMed          Journal:  Prog Med Virol        ISSN： 0079-645X


× No keyword cloud information.
  18 in total

1.  AN OUTBREAK OF ASEPTIC MENINGITIS DUE TO ECHO 25 VIRUS.

Authors:  A E KELEN; J M LESIAK; N A LABZOFFSKY
Journal:  Can Med Assoc J       Date:  1964-06-13       Impact factor: 8.262

2.  EPIDEMIOLOGICAL ASPECTS OF COXSACKIE AND ECHO VIRUS INFECTIONS IN TROPICAL AREAS.

Authors:  J P FOX
Journal:  Am J Public Health Nations Health       Date:  1964-07

3.  [PECULIARITIES IN VIRUS EXCRETION AND ANTIBODY FORMATION AFTER ADMINISTRATION OF A "BALANCED" LIVE VACCINE MIXTURE OF POLIOVIRUS TYPES I AND II].

Authors:  W HENIGST; F MUELLER; F WUERSCHING
Journal:  Z Hyg Infektionskr       Date:  1963-12-23

4.  Virological aspects of Coxsackie virus infections.

Authors:  I DOMOK
Journal:  Arch Gesamte Virusforsch       Date:  1963

5.  [Epidemiology of ECHO virus infections].

Authors:  A GIOVANARDI; F BERGAMINI
Journal:  Arch Gesamte Virusforsch       Date:  1963

6.  [On the occurrence of a variant of type 25 ECHO virus].

Authors:  W HENIGST
Journal:  Arch Gesamte Virusforsch       Date:  1963 Spring-Fall

7.  Enterovirus survey in children after mass vaccination with live attenuated polioviruses.

Authors:  I DOMOK; E MOLNAR; A JANCSO; M DANIEL
Journal:  Br Med J       Date:  1962-03-17

8.  [Orienting studies on the presence of neutralizing antibodies against Coxsackie viruses in a healthy population].

Authors:  W HENIGST
Journal:  Z Hyg Infektionskr       Date:  1962

Review 9.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

10.  Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance.

Authors:  J R Gebhard; C M Perry; S Harkins; T Lane; I Mena; V C Asensio; I L Campbell; J L Whitton
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.